Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 6,400.00
-350.00 (-5.19%)
At close: Feb 26, 2026
123.78% (1Y)
| Market Cap | 221.92B +173.3% |
| Revenue (ttm) | 25.95B +7.7% |
| Net Income | -27.82B |
| EPS | -693.34 |
| Shares Out | 34.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 704,303 |
| Average Volume | 592,966 |
| Open | 6,750.00 |
| Previous Close | 6,750.00 |
| Day's Range | 6,400.00 - 6,750.00 |
| 52-Week Range | 2,170.00 - 10,180.00 |
| Beta | 1.06 |
| RSI | 37.22 |
| Earnings Date | Nov 14, 2025 |